Dose of Labeled Cholesterol for Kinetics: A Pilot Study
NCT ID: NCT02065817
Last Updated: 2016-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2014-02-28
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
NCT00217061
Reverse Cholesterol Transport (RCT) Study
NCT01031758
Statin Therapy to Improve Medication Adherence
NCT01894217
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
NCT01259791
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
NCT00587717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tracer
stable isotope of cholesterol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stable isotope of cholesterol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Metabolic disease
* Hematologic disorder
* Liver or kidney disease
* phenylketonuria
* Currently taking lipid lowering medications or any other drugs that could affect lipid metabolism
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ananda Basu
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John M Miles, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-004890
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.